中访网数据上海君实生物医药科技股份有限公司于2026年3月4日向香港交易及结算所有限公司提交了截至2026年2月28日的证券变动月报表。报告显示,公司法定股本及已发行股份在本月内均未发生变动。根据报表,公司法定股本总额为人民币1,026,689,871元,由H股和A股两部分构成。其中,H股法定股本为人民币260,295,700元,对应260,295,700股已发行普通股,股票代码为01877,于...
Source Link中访网数据上海君实生物医药科技股份有限公司于2026年3月4日向香港交易及结算所有限公司提交了截至2026年2月28日的证券变动月报表。报告显示,公司法定股本及已发行股份在本月内均未发生变动。根据报表,公司法定股本总额为人民币1,026,689,871元,由H股和A股两部分构成。其中,H股法定股本为人民币260,295,700元,对应260,295,700股已发行普通股,股票代码为01877,于...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.